Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies
An optimized lymph node yield leads to better survival in colon cancer, but extended lymphadenectomy is not associated with survival benefits. Lymphatic mapping shows several colon cancers feature aberrant drainage pathways inducing local recurrence when not resected. Currently, different protocols...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/12/3196 |
_version_ | 1797436094976884736 |
---|---|
author | Katharina Lucas Nathaniel Melling Anastasios D. Giannou Matthias Reeh Oliver Mann Thilo Hackert Jakob R. Izbicki Daniel Perez Julia K. Grass |
author_facet | Katharina Lucas Nathaniel Melling Anastasios D. Giannou Matthias Reeh Oliver Mann Thilo Hackert Jakob R. Izbicki Daniel Perez Julia K. Grass |
author_sort | Katharina Lucas |
collection | DOAJ |
description | An optimized lymph node yield leads to better survival in colon cancer, but extended lymphadenectomy is not associated with survival benefits. Lymphatic mapping shows several colon cancers feature aberrant drainage pathways inducing local recurrence when not resected. Currently, different protocols exist for lymphatic mapping procedures. This meta-analysis assessed which protocol has the best capacity to detect tumor-draining and possibly metastatic lymph nodes. A systematic review was conducted according to PRISMA guidelines, including prospective trials with in vivo tracer application. The risk of bias was evaluated using the QUADAS-2 tool. Traced lymph nodes, total resected lymph nodes, and aberrant drainage detection rate were analyzed. Fifty-eight studies met the inclusion criteria, of which 42 searched for aberrant drainage. While a preoperative tracer injection significantly increased the traced lymph node rates compared to intraoperative tracing (30.1% (15.4, 47.3) vs. 14.1% (11.9, 16.5), <i>p</i> = 0.03), no effect was shown for the tracer used (<i>p</i> = 0.740) or the application sites comparing submucosal and subserosal injection (22.9% (14.1, 33.1) vs. 14.3% (12.1, 16.8), <i>p</i> = 0.07). Preoperative tracer injection resulted in a significantly higher rate of detected aberrant lymph nodes compared to intraoperative injection (26.3% [95% CI 11.5, 44.0] vs. 2.5% [95% CI 0.8, 4.7], <i>p</i> < 0.001). Analyzing 112 individual patient datasets from eight studies revealed a significant impact on aberrant drainage detection for injection timing, favoring preoperative over intraoperative injection (OR 0.050 [95% CI 0.010–0.176], <i>p</i> < 0.001) while indocyanine green presented itself as the superior tracer (OR 0.127 [95% CI 0.018–0.528], <i>p</i> = 0.012). Optimized lymphatic mapping techniques result in significantly higher detection of aberrant lymphatic drainage patterns and thus enable a personalized approach to reducing local recurrence. |
first_indexed | 2024-03-09T10:57:44Z |
format | Article |
id | doaj.art-e896ef3d5b9d4ded856ab19928986745 |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-09T10:57:44Z |
publishDate | 2023-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-e896ef3d5b9d4ded856ab199289867452023-12-01T01:32:40ZengMDPI AGCancers2072-66942023-06-011512319610.3390/cancers15123196Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed StudiesKatharina Lucas0Nathaniel Melling1Anastasios D. Giannou2Matthias Reeh3Oliver Mann4Thilo Hackert5Jakob R. Izbicki6Daniel Perez7Julia K. Grass8Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyDepartment of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, GermanyAn optimized lymph node yield leads to better survival in colon cancer, but extended lymphadenectomy is not associated with survival benefits. Lymphatic mapping shows several colon cancers feature aberrant drainage pathways inducing local recurrence when not resected. Currently, different protocols exist for lymphatic mapping procedures. This meta-analysis assessed which protocol has the best capacity to detect tumor-draining and possibly metastatic lymph nodes. A systematic review was conducted according to PRISMA guidelines, including prospective trials with in vivo tracer application. The risk of bias was evaluated using the QUADAS-2 tool. Traced lymph nodes, total resected lymph nodes, and aberrant drainage detection rate were analyzed. Fifty-eight studies met the inclusion criteria, of which 42 searched for aberrant drainage. While a preoperative tracer injection significantly increased the traced lymph node rates compared to intraoperative tracing (30.1% (15.4, 47.3) vs. 14.1% (11.9, 16.5), <i>p</i> = 0.03), no effect was shown for the tracer used (<i>p</i> = 0.740) or the application sites comparing submucosal and subserosal injection (22.9% (14.1, 33.1) vs. 14.3% (12.1, 16.8), <i>p</i> = 0.07). Preoperative tracer injection resulted in a significantly higher rate of detected aberrant lymph nodes compared to intraoperative injection (26.3% [95% CI 11.5, 44.0] vs. 2.5% [95% CI 0.8, 4.7], <i>p</i> < 0.001). Analyzing 112 individual patient datasets from eight studies revealed a significant impact on aberrant drainage detection for injection timing, favoring preoperative over intraoperative injection (OR 0.050 [95% CI 0.010–0.176], <i>p</i> < 0.001) while indocyanine green presented itself as the superior tracer (OR 0.127 [95% CI 0.018–0.528], <i>p</i> = 0.012). Optimized lymphatic mapping techniques result in significantly higher detection of aberrant lymphatic drainage patterns and thus enable a personalized approach to reducing local recurrence.https://www.mdpi.com/2072-6694/15/12/3196colon cancerlymphatic mappinglymph node metastasesaberrant drainageICGcurative surgery |
spellingShingle | Katharina Lucas Nathaniel Melling Anastasios D. Giannou Matthias Reeh Oliver Mann Thilo Hackert Jakob R. Izbicki Daniel Perez Julia K. Grass Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies Cancers colon cancer lymphatic mapping lymph node metastases aberrant drainage ICG curative surgery |
title | Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies |
title_full | Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies |
title_fullStr | Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies |
title_full_unstemmed | Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies |
title_short | Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies |
title_sort | lymphatic mapping in colon cancer depending on injection time and tracing agent a systematic review and meta analysis of prospective designed studies |
topic | colon cancer lymphatic mapping lymph node metastases aberrant drainage ICG curative surgery |
url | https://www.mdpi.com/2072-6694/15/12/3196 |
work_keys_str_mv | AT katharinalucas lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies AT nathanielmelling lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies AT anastasiosdgiannou lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies AT matthiasreeh lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies AT olivermann lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies AT thilohackert lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies AT jakobrizbicki lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies AT danielperez lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies AT juliakgrass lymphaticmappingincoloncancerdependingoninjectiontimeandtracingagentasystematicreviewandmetaanalysisofprospectivedesignedstudies |